Logo

American Heart Association

  41
  0


Final ID:

Discussant

  • Morin, Daniel  ( Univ of CA San Francisco , San Francisco , California , United States )
  • Author Disclosures:
    Daniel Morin: DO have relevant financial relationships ; Consultant:Zoll:Active (exists now) ; Consultant:Abbott:Active (exists now) ; Speaker:Zoll:Active (exists now)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Featured Science in EP

Monday, 11/10/2025 , 08:00AM - 09:15AM

Featured Science

More abstracts on this topic:
Primary Results from the Post Approval Study of a Next Generation Wearable Cardioverter Defibrillator System: the ACE-PAS Trial

Poole Jeanne, Gleva Marye, Branch Kelley, Birgersdotter-green Ulrika, Doshi Rahul, Mahankali Sridhar Arun Raghav, Wang Melinda, Gustavson Laura, Zulueta Shirley

Pulsed Field Ablation versus Sham Ablation to Treat Atrial Fibrillation
(The PFA-SHAM Trial)

Osmancik Pavel, Karel Tomas, Sediva Lucie, Stepanek Lubomir, Lekesova Veronika, Hala Pavel, Vesela Jana, Karch Jakub, Filipcová Vera, Fischer Jakub, Whang William, Neuzil Petr, Reddy Vivek, Hozmanova Jana, Petru Jan, Hozman Marek, Kralovec Stepan, Herman Dalibor, Tichy Marco, Waldauf Petr

More abstracts from these authors:
Relationships Between Degree of Obesity, Transthoracic Impedance, and Cardioversion Efficacy

Sanchez Alexandra, Morin Daniel, Murphy Barret, Aymond Joshua, Bernard Michael, Hiltbold Aimee, Khatib Sammy, Polin Glenn, Rogers Paul, Castine Michael

You have to be authorized to contact abstract author. Please, Login
Not Available